Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma.
Niwa K, Kawakita D, Nagao T, Takahashi H, Saotome T, Okazaki M, Yamazaki K, Okamoto I, Hirai H, Saigusa N, Fushimi C, Masubuchi T, Miura K, Okazaki SI, Matsui H, Okada T, Iwaki S, Matsuki T, Hanyu K, Tsukahara K, Oridate N, Tada Y.
Niwa K, et al.
Sci Rep. 2020 Oct 12;10(1):16988. doi: 10.1038/s41598-020-73965-6.
Sci Rep. 2020.
PMID: 33046752
Free PMC article.